Next Article in Journal
Study on Electrochemical Degradation of Nicosulfuron by IrO2-Based DSA Electrodes: Performance, Kinetics, and Degradation Mechanism
Previous Article in Journal
Psychological Distress and Social Functioning in Elderly Spanish People: A Gender Analysis
Article Menu
Issue 3 (February-1) cover image

Export Article

Open AccessArticle
Int. J. Environ. Res. Public Health 2019, 16(3), 342;

The Waiting Time of Prostate Cancer Patients in Poland

Department of Public Health, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-082 Olsztyn, Al. Warszawska 30, Poland
Department of Public Health, Medical University of Warsaw, 02-097 Warszawa, Ul. Nielubowicza 5, Poland
Radiotherapy Center Nu-Med, 82-300 Elblag, Ul. Królewiecka 146, Poland
Department of Oncology and Radiotherapy, Medical University of Silesia in Katowice, 40-515 Katowice, Ul. Ceglana 35, Poland
Department of Oncology, Collegium Medicum, School of Medicine, University of Warmia and Mazury in Olsztyn, 10-228 Olsztyn, Al. Wojska Polskiego 37, Poland
Author to whom correspondence should be addressed.
Received: 10 December 2018 / Revised: 14 January 2019 / Accepted: 23 January 2019 / Published: 26 January 2019
Full-Text   |   PDF [415 KB, uploaded 26 January 2019]   |  


Background: Prostate cancer is the second most common reason of mortality due to cancer among men in Poland. The study aimed to determine the waiting time for diagnosis and treatment of prostate cancer. Methods: The study was carried out on patients treated for prostate cancer from May 2014 to February 2015 at five oncological centres in Poland. The median waiting time was measured from the time cancer was suspected to the histopathological diagnosis (SDI), from the cancer suspicion to the start of treatment (STI) and from the diagnosis to the start of treatment (DTI). Results: 123 males treated for prostate cancer were included for analysis. The median time for SDI, STI and DTI was 7.7, 18.7 and 8.7 weeks, respectively. Place of residence was the only factor which influenced STI (p = 0.003). For patients, who started treatment with radiation therapy DTI was longer than for other patients (p < 0.001). Conclusions: Median times of STI, SDI and DTI for prostate cancer patients in Poland are similar to the intervals described in other countries. Patients, who lived further from an oncology centre waited longer for treatment. The impact of waiting time in the case of prostate cancer on improving the prognosis is still unclear. View Full-Text
Keywords: prostate cancer; waiting time; health services prostate cancer; waiting time; health services

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Osowiecka, K.; Nawrocki, S.; Kurowicki, M.; Rucinska, M. The Waiting Time of Prostate Cancer Patients in Poland. Int. J. Environ. Res. Public Health 2019, 16, 342.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top